NORTHERN TRUST CORP - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 246 filers reported holding EDITAS MEDICINE INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$6,932,218
+10.2%
888,746
+16.3%
0.00%0.0%
Q2 2023$6,288,617
+29.5%
764,109
+14.1%
0.00%0.0%
Q1 2023$4,854,811
-19.0%
669,629
-0.9%
0.00%0.0%
Q4 2022$5,994,807
-36.8%
675,852
-12.8%
0.00%
-50.0%
Q3 2022$9,488,000
+22.8%
775,068
+18.6%
0.00%0.0%
Q2 2022$7,729,000
-39.4%
653,365
-2.5%
0.00%0.0%
Q1 2022$12,744,000
-30.8%
670,018
-3.5%
0.00%
-33.3%
Q4 2021$18,425,000
-36.7%
693,984
-2.0%
0.00%
-40.0%
Q3 2021$29,100,000
-29.3%
708,366
-2.5%
0.01%
-28.6%
Q2 2021$41,166,000
+28.9%
726,817
-4.4%
0.01%
+16.7%
Q1 2021$31,944,000
-40.9%
760,571
-1.4%
0.01%
-45.5%
Q4 2020$54,063,000
+142.6%
771,116
-2.9%
0.01%
+120.0%
Q3 2020$22,289,000
-1.3%
794,340
+4.1%
0.01%0.0%
Q2 2020$22,578,000
+80.6%
763,299
+21.1%
0.01%
+25.0%
Q1 2020$12,502,000
-31.4%
630,405
+2.4%
0.00%0.0%
Q4 2019$18,225,000
+30.5%
615,485
+0.2%
0.00%
+33.3%
Q3 2019$13,970,000
+1.4%
614,330
+10.3%
0.00%0.0%
Q2 2019$13,779,000
+2.8%
556,987
+1.6%
0.00%0.0%
Q1 2019$13,398,000
+7.8%
547,973
+0.3%
0.00%0.0%
Q4 2018$12,426,000
-28.2%
546,239
+0.4%
0.00%
-25.0%
Q3 2018$17,316,000
-7.6%
544,195
+4.1%
0.00%
-20.0%
Q2 2018$18,732,000
+34.6%
522,762
+24.5%
0.01%
+25.0%
Q1 2018$13,917,000
+21.2%
419,861
+12.4%
0.00%
+33.3%
Q4 2017$11,478,000
+26.9%
373,507
-0.9%
0.00%
+50.0%
Q3 2017$9,046,000
+44.5%
376,742
+1.0%
0.00%0.0%
Q2 2017$6,261,000
+160.0%
373,149
+245.9%
0.00%
+100.0%
Q1 2017$2,408,000
+65.7%
107,876
+20.5%
0.00%
Q4 2016$1,453,000
+22.0%
89,538
+1.3%
0.00%
Q3 2016$1,191,000
-33.2%
88,351
+21.0%
0.00%
-100.0%
Q2 2016$1,782,000
+244.0%
73,023
+386.9%
0.00%
Q1 2016$518,00014,9990.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 1,674,435$51,455,00013.05%
TRV GP III, LLC 906,176$27,847,0009.75%
ARK Investment Management 1,112,845$34,198,0002.72%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,709,400$52,530,0002.07%
Casdin Capital, LLC 133,333$4,097,0001.00%
Global Thematic Partners, LLC 614,052$18,869,0000.62%
MORGENS WATERFALL VINTIADIS & CO INC 20,000$615,0000.48%
Ghost Tree Capital, LLC 65,000$1,997,0000.47%
ACUTA CAPITAL PARTNERS, LLC 64,000$1,967,0000.37%
VIKING GLOBAL INVESTORS LP 1,709,401$52,530,0000.32%
View complete list of EDITAS MEDICINE INC shareholders